infliximab, rituximab) given at infusion centers
Clinical studies show comparable effectiveness in blood sugar control and weight loss between daily oral and weekly injectable semaglutide when doses are optimized
Valid reasons for discontinuation include intolerable side effects, pregnancy or planning pregnancy, development of certain medical conditions, inadequate therapeutic response, or personal choice
These cognitive-enhancing properties have been demonstrated in animal studies to it can improve memory and learning abilities
Early communication ensures that simple causes like low blood sugar, dehydration, or nutrient imbalance are corrected quickly and that more serious issues are not missed
control FoB (Supplementary Fig